{"id":34199,"date":"2026-07-29T12:04:11","date_gmt":"2026-07-29T16:04:11","guid":{"rendered":"https:\/\/therapytoronto.ca\/news\/?p=34199"},"modified":"2026-07-29T12:02:36","modified_gmt":"2026-07-29T16:02:36","slug":"vitamin-b3-treatment-may-halt-severity-of-rare-genetic-disease","status":"publish","type":"post","link":"https:\/\/therapytoronto.ca\/news\/2026\/07\/vitamin-b3-treatment-may-halt-severity-of-rare-genetic-disease\/","title":{"rendered":"Vitamin B3 treatment may halt severity of rare genetic disease"},"content":{"rendered":"<p>Children with a rare and often fatal genetic condition may benefit from early treatment with vitamin B3, halting their significant deterioration, according to a new study.<\/p>\n<p>The research, led by <a href=\"https:\/\/www.mcri.edu.au\/\">Murdoch Children\u2019s Research Institute (MCRI)<\/a> and the <a href=\"https:\/\/www.uni.lu\/lcsb-en\/research\/\">Luxembourg Centre for Systems Biomedicine (LCSB)<\/a>, significantly expands our knowledge of NAXD deficiency, showing that high-dose niacin therapy could improve survival outcomes.<\/p>\n<p>The team also identified nine additional cases of the disorder, showing that the condition can appear in a wider range of ways than previously recognised, including problems affecting the nervous system, heart and development before birth.<\/p>\n<p>The healthy form of the NAXD gene allows cells to keep making the energy our body needs. NAXD deficiency is an ultra-rare genetic disorder caused by faults in the gene. Researchers believe vitamin B3 may help support energy-producing pathways. Affected children are often born healthy, but common childhood illnesses such as influenza or COVID-19 can trigger sudden and severe complications which mostly affect the brain and heart.<\/p>\n<p>Published in the <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jimd.70217\"><em>Journal of Inherited Metabolic Disease<\/em><\/a><em><u>,<\/u><\/em> the study helped nine children receive a NAXD diagnosis, who were referred to MCRI for further testing. Encouragingly, four children who were treated with a high vitamin B3 dose survived fever and infections that could have otherwise caused serious health problems or death. Two experienced disease\u00a0onset\u00a0following\u00a0a\u00a0COVID-19\u00a0infection, highlighting the vulnerability of\u00a0children\u00a0with the condition to infection and the need for\u00a0them to stay up to date with vaccinations.<\/p>\n<p>MCRI <a href=\"https:\/\/www.mcri.edu.au\/researcher-details\/nicole-van-bergen\">Dr Nicole Van Bergen<\/a> said the findings could change the outlook for children living with NAXD deficiency by highlighting the importance of early recognition and intervention.<\/p>\n<p>\u201cThis disorder is often devastating, with children deteriorating rapidly after even mild illness,\u201d she said. \u201cCommon infections and minor injuries can end up in life-threatening complications.<\/p>\n<p>\u201cBut seeing children survive illnesses after treatment with high-dose vitamin B3 offers new hope for affected children and their families. While further research into the long-term use of vitamin B3 is needed, the condition should now be considered as a treatable disease.<\/p>\n<p>\u201cOur team is also testing medicines that are proven to increase cellular energy levels to see if they can also safely and effectively treat NAXD. This approach could provide a lower-cost alternative to developing a new drug from scratch.\u201d<\/p>\n<p>Importantly, the study also broadens our understanding of the clinical presentation of NAXD deficiency, discovering that changes in different parts of the NAXD gene were linked to distinct forms of the disease.<\/p>\n<p>It found four children experienced the more typical patterns of neurological deterioration, including seizures and developmental delay following illness. Another four developed serious heart complications, while one case of severe neurodegeneration before birth resulted in stillbirth.<\/p>\n<p>Dr Van Bergen said the findings may help clinicians diagnose children earlier, particularly those with additional, non-typical neurological traits and heart symptoms.<\/p>\n<p>\u201cFuture research will focus on exploring these different subtypes of disease,\u201d she said. \u201cHowever, for a disease only identified in 2019, our work represents a rapid and significant step forward in understanding and treating NAXD deficiency.\u201d<\/p>\n<p>Researchers from the University of Melbourne, Nickelaus Children\u2019s Health System, Children\u2019s Hospital of Philadelphia, Hospital de Ni\u00f1os Dr. Ricardo Guti\u00e9rrez, The Children&#8217;s Hospital at Westmead, University of Sydney, University Hospital Southampton NHS Foundation Trust, University of Southampton, Vietnam National Children\u2019s Hospital and the Queensland Children\u2019s Hospital also contributed to the research.<\/p>\n<!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>Children with a rare and often fatal genetic condition may benefit from early treatment with vitamin B3, halting their significant deterioration, according to a new study. The research, led by Murdoch Children\u2019s Research Institute (MCRI) and the Luxembourg Centre for Systems Biomedicine (LCSB), significantly expands our knowledge of NAXD deficiency, showing that high-dose niacin therapy&hellip;&nbsp;<!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>\n","protected":false},"author":3,"featured_media":9629,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"no","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[336],"tags":[661,45,664,662,663,660],"class_list":["post-34199","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nutrition-2","tag-b","tag-children","tag-deterioration","tag-dosage","tag-naxd-deficiency","tag-vitamins"],"_links":{"self":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/34199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/comments?post=34199"}],"version-history":[{"count":1,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/34199\/revisions"}],"predecessor-version":[{"id":34200,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/34199\/revisions\/34200"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/media\/9629"}],"wp:attachment":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/media?parent=34199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/categories?post=34199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/tags?post=34199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}